Literature DB >> 11455466

Role of endoscopic endoprostheses in proximal malignant biliary obstruction.

J A Tibble1, S R Cairns.   

Abstract

The management of hilar strictures is dependent upon their resectability and may therefore require a multidisciplinary approach. However, resectability rates for such tumors are reported to be in the region of 15%-20%, and, therefore, palliative therapy will be the mainstay of treatment for most patients. With the presenting symptoms being those of obstructive jaundice and the consequences of cholestasis, a significant improvement in morbidity can be obtained by achieving biliary drainage. A number of options are available, including the placement of Teflon or expandable metallic endoprostheses by either the endoscopic or percutaneous route. Some considerable debate exists as to which route of stent placement is best, and in many circumstances the decision will depend on the availability of local services. Some have suggested that success rates with percutaneous stenting are superior to those for endoscopic placement, but the latter technique may be associated with fewer complications. In competent hands, endoscopic placement does achieve a high rate of success and it should be remembered that a combined approach may further improve success rates. The debate over the use of plastic versus metallic stents is centered around the higher rates of stent occlusion/migration for plastic stents seen in some studies, although a stent change is usually possible. An additional advantage of metallic stents is that they may provide drainage of the side branches of the biliary tree through the mesh. However, possible drawbacks may be a greater difficulty in placement of a second stent where a first provides inadequate drainage, and cost issues often have to be taken into consideration. Considerable debate exists over the optimum number of stents required to achieve adequate drainage and minimize the risks of cholangitis. There is good evidence that if overfilling of the biliary tree with contrast is avoided with only the segments to be drained visualized, a single stent may be all that is required, while others argue that placement of more than one stent may improve survival. In the following review we discuss these issues, and conclude by considering success rates and complications following endoprosthesis insertion; we also discuss the prognosis of patients treated in this way.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11455466     DOI: 10.1007/s005340170033

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  8 in total

Review 1.  Current management of biliary strictures.

Authors:  Jennifer G Hall; Theodore N Pappas
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

2.  One-step palliative treatment method for obstructive jaundice caused by unresectable malignancies by percutaneous transhepatic insertion of an expandable metallic stent.

Authors:  Hiroshi Yoshida; Yasuhiro Mamada; Nobuhiko Taniai; Yoshiaki Mizuguchi; Tetsuya Shimizu; Shigeki Yokomuro; Takayuki Aimoto; Yoshiharu Nakamura; Eiji Uchida; Yasuo Arima; Manabu Watanabe; Eiichi Uchida; Takashi Tajiri
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

Review 3.  Endoscopic and Photodynamic Therapy of Cholangiocarcinoma.

Authors:  Benjamin Meier; Karel Caca
Journal:  Visc Med       Date:  2016-11-30

4.  Comparison of the influence of plastic and fully covered metal biliary stents on the accuracy of EUS-FNA for the diagnosis of pancreatic cancer.

Authors:  Ali A Siddiqui; Michael Fein; Thomas E Kowalski; David E Loren; Mohamad A Eloubeidi
Journal:  Dig Dis Sci       Date:  2012-04-21       Impact factor: 3.199

5.  Radiofrequency ablation as a treatment for hilar cholangiocarcinoma.

Authors:  Wei-Jun Fan; Pei-Hong Wu; Liang Zhang; Jin-Hua Huang; Fu-Jun Zhang; Yang-Kui Gu; Ming Zhao; Xiang-Long Huang; Chang-Yu Guo
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

6.  Emergency percutaneous treatment in surgical bile duct injury.

Authors:  Gianpaolo Carrafiello; Domenico Laganà; Massimiliano Dizonno; Andrea Ianniello; Elisa Cotta; Gianlorenzo Dionigi; Renzo Dionigi; Carlo Fugazzola
Journal:  Emerg Radiol       Date:  2008-05-08

7.  Current and emerging therapies for the treatment of pancreatic cancer.

Authors:  Rebecca A Moss; Clifton Lee
Journal:  Onco Targets Ther       Date:  2010-09-07       Impact factor: 4.147

Review 8.  Endoscopic Stenting in Hilar Cholangiocarcinoma: When, How, and How Much to Drain?

Authors:  Andrea Tringali; Ivo Boškoski; Guido Costamagna
Journal:  Gastroenterol Res Pract       Date:  2019-11-04       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.